Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG.

BMC Microbiol. 2015 Mar 21;15(1):67.

PMID:
25888448
2.

Changes in the Lemann Index values during the First Years of Crohn's Disease.

Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J.

Clin Gastroenterol Hepatol. 2015 Mar 9. pii: S1542-3565(15)00246-3. doi: 10.1016/j.cgh.2015.02.041. [Epub ahead of print]

PMID:
25766650
3.

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H.

J Crohns Colitis. 2015 Apr;9(4):349-55. doi: 10.1093/ecco-jcc/jju024. Epub 2014 Dec 28.

PMID:
25547977
4.

Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease.

Richard ML, Lamas B, Liguori G, Hoffmann TW, Sokol H.

Inflamm Bowel Dis. 2015 Mar;21(3):656-65. doi: 10.1097/MIB.0000000000000261.

PMID:
25545379
5.

Probiotics and antibiotics in IBD.

Sokol H.

Dig Dis. 2014;32 Suppl 1:10-7. doi: 10.1159/000367820. Epub 2014 Dec 17.

PMID:
25531348
6.

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.

Laval L, Martin R, Natividad J, Chain F, Miquel S, de Maredsous CD, Capronnier S, Sokol H, Verdu E, van Hylckama Vlieg J, Bermúdez-Humarán L, Smokvina T, Langella P.

Gut Microbes. 2015 Jan 2;6(1):1-9. doi: 10.4161/19490976.2014.990784. Epub 2015 Jan 14.

PMID:
25517879
7.

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR.

Inflamm Bowel Dis. 2015 Jan;21(1):60-70. doi: 10.1097/MIB.0000000000000225.

PMID:
25517594
8.

Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

Regnault H, Bourrier A, Lalande V, Nion-Larmurier I, Sokol H, Seksik P, Barbut F, Cosnes J, Beaugerie L.

Dig Liver Dis. 2014 Dec;46(12):1086-92. doi: 10.1016/j.dld.2014.09.003. Epub 2014 Oct 5.

PMID:
25294795
9.

An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse.

Liao J, Jijon HB, Kim IR, Goel G, Doan A, Sokol H, Bauer H, Herrmann BG, Lassen KG, Xavier RJ.

PLoS One. 2014 Sep 30;9(9):e108777. doi: 10.1371/journal.pone.0108777. eCollection 2014.

10.

Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.

Kumar V, Cheng SC, Johnson MD, Smeekens SP, Wojtowicz A, Giamarellos-Bourboulis E, Karjalainen J, Franke L, Withoff S, Plantinga TS, van de Veerdonk FL, van der Meer JW, Joosten LA, Sokol H, Bauer H, Herrmann BG, Bochud PY, Marchetti O, Perfect JR, Xavier RJ, Kullberg BJ, Wijmenga C, Netea MG.

Nat Commun. 2014 Sep 8;5:4675. doi: 10.1038/ncomms5675.

PMID:
25197941
11.

Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii.

Sokol H, Langella P.

Inflamm Bowel Dis. 2014 Jul;20(7):E18. doi: 10.1097/MIB.0000000000000071. No abstract available.

PMID:
24859301
12.

Complications and surgery in the inflammatory bowel diseases biological era.

Sokol H, Seksik P, Cosnes J.

Curr Opin Gastroenterol. 2014 Jul;30(4):378-84. doi: 10.1097/MOG.0000000000000078. Review.

PMID:
24840000
13.

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.

Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E, Allez M, Mary JY, Sokol H, Colombel JF, Seksik P.

Inflamm Bowel Dis. 2014 Jun;20(6):978-86. doi: 10.1097/MIB.0000000000000036.

PMID:
24788220
14.

Letter: not the end of the role of anti-viral therapy in ulcerative colitis with cytomegalovirus reactivation - authors' reply.

Delvincourt M, Sokol H.

Aliment Pharmacol Ther. 2014 May;39(10):1247-8. doi: 10.1111/apt.12722. No abstract available.

PMID:
24735149
15.

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG.

Hum Vaccin Immunother. 2014;10(6):1611-21. doi: 10.4161/hv.28549. Epub 2014 Apr 14.

PMID:
24732667
16.

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F.

PLoS Biol. 2014 Apr 8;12(4):e1001833. doi: 10.1371/journal.pbio.1001833. eCollection 2014 Apr.

17.

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Gut Microbes. 2014 Mar-Apr;5(2):146-51. doi: 10.4161/gmic.27651. Epub 2014 Jan 22.

18.

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H.

Aliment Pharmacol Ther. 2014 Apr;39(7):712-20. doi: 10.1111/apt.12650. Epub 2014 Feb 9.

PMID:
24506221
19.

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease.

Rajca S, Seksik P, Bourrier A, Sokol H, Nion-Larmurier I, Beaugerie L, Cosnes J.

J Crohns Colitis. 2014 Aug 1;8(8):819-24. doi: 10.1016/j.crohns.2013.12.022. Epub 2014 Jan 16.

PMID:
24439392
20.

Bacterial protein signals are associated with Crohn's disease.

Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, Mondot S, Sykacek P, Sokol H, Blon F, Lepercq P, Levenez F, Valot B, Carré W, Loux V, Pons N, David O, Schaeffer B, Lepage P, Martin P, Monnet V, Seksik P, Beaugerie L, Ehrlich SD, Gibrat JF, Van Dorsselaer A, Doré J.

Gut. 2014 Oct;63(10):1566-77. doi: 10.1136/gutjnl-2012-303786. Epub 2014 Jan 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk